PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Hematology & CBC/HbA2
Hematology & CBCBeta-Thalassemia Trait Screening

Hemoglobin A2 Percentage (HbA2)

Minor adult hemoglobin tetramer composed of two alpha and two delta globin chains (alpha-2 delta-2).

Standard Range1.5 - 3.5%
Optimal Longevity2.0 - 3.2%
Measurement Unit%
Organ SystemBeta-Thalassemia Trait Screening
Routine Panels:Hemoglobin ElectrophoresisThalassemia Screen

Standard vs. Optimal Reference Ranges%

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: %
%
Presets:
1 %Optimal Zone Target5 %
Optimal Longevity Zone(2.6 %)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

1.5 - 3.5%

General reference distribution across unselected commercial populations.

Optimal Longevity Target

2.0 - 3.2%

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Synthesized in small amounts under normal conditions; beta-globin gene mutations divert excess alpha chains to pair with delta chains.

Differential Diagnosis

Elevated Levels (HbA2 High)

  • •Beta-Thalassemia Trait (Minor, HbA2 typically 3.6% to 6.5%)
  • •Hyperthyroidism

Low Levels (HbA2 Low)

  • •Iron deficiency anemia (falsely lowers HbA2, masking mild thalassemia)
  • •Alpha-thalassemia trait
  • •Delta-thalassemia

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Hemoglobin A2 Percentage (HbA2) plays an essential physiological role in beta-thalassemia trait screening. Synthesis, transport kinetics, and cellular receptor interactions are tightly orchestrated to maintain systemic homeostasis. Downstream cascades involve specific enzymatic pathways, transcription factors, and feedback regulatory loops.
Longevity Risk Architecture & Epidemiology
Elevated HbA2 (>3.5%) is the definitive diagnostic hallmark for Beta-Thalassemia Minor (Trait), distinguishing it from iron deficiency anemia.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker quantification for HbA2
  • Targeted organ system imaging or functional dynamic testing related to beta-thalassemia trait screening
  • Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Molecular Physiology of Hemoglobin A2 Percentage - The New England Journal of Medicine (2021). PMID: 34090124
  • [2]HbA2 Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Common Panels:Hemoglobin ElectrophoresisThalassemia Screen
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Hemoglobin A2 Percentage (HbA2) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Hematology & CBC Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousErythrocyte Pyruvate Kinase (PK Activity)Hematology & CBCNextFetal Hemoglobin Percentage (HbF)Hematology & CBC